We are a Biologics CDMO, with you on your biologics journey. We have what it takes to help you deliver advanced medicines. It's within us.
Location: Spain, Navarre, Pamplona
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Idinvest P... | idinvest.c... |
| - | Keensight ... | keensightc... |
Mentions in press and media 18
| Date | Title | Description |
| 01.02.2024 | Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO | - |
| 16.12.2023 | Caliway Biopharmaceuticals Secures Over $100M | Caliway Biopharmaceuticals, a Taipei, Taiwan-based clinical-stage biopharmaceutical company listed on the stock market in Taiwan (TPEX6919), closed an oversubscribed capital raise, securing over $100M by issuing 8 million new shares. The co... |
| 12.05.2023 | Global Biopharmaceuticals Market is Expected to Have a Value of USD 566 Billion in 2032; CAGR of 8.2% | - |
| 11.07.2022 | 3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial. | 3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial. Mon, Jul 11, 2022 10:00 CET Report this content Mucormycosis is a difficult to treat invasive fung... |
| 26.05.2022 | Biopharmaceuticals Contract Manufacturing Market Report 2022: A $27.3 Billion Market by 2030 - Rise in Investment by CMOs for Capacity Expansion | Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, by Service (Upstream, Downstream, Fill/Finish), by Product (Biologics), by Region and Se... |
| 01.07.2021 | RegeneRx Biopharmaceuticals : Closes $2 Million Private Placement (Form 8-K) | RegeneRx Biopharmaceuticals, Inc. Closes $2 Million Private Placement ROCKVILLE, Md. (July 1, 2021) - RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ('RegeneRx'), a clinical-stage drug development company focused on tissue protection, repa... |
| 29.10.2020 | Elpis Biopharmaceuticals Closes $30 Million Series A | LEXINGTON, Mass.--(BUSINESS WIRE)--Elpis Biopharmaceuticals today announced the closing of a $30 million Series A financing to propel solid tumor and hematological disease therapeutics through pre-clinical studies, which brings the company ... |
| 23.07.2019 | Keensight Capital toma una participación mayoritaria en 3P Biopharmaceuticals, participada por varios fondos de CR | 23/07/2019 KEENSIGHT CAPITAL TOMA UNA PARTICIPACIÓN MAYORITARIA EN 3P BIOPHARMACEUTICALS, PARTICIPADA POR VARIOS FONDOS DE CAPITAL RIESGO. La entidad de capital riesgo Keensight Capital ha llevado a cabo su segunda inversión en España con... |
| 17.03.2019 | Raleigh-based Innovate Biopharmaceuticals Raises $5.5M by Selling Debt | Innovate Biopharmaceuticals Inc., a Raleigh-based clinical stage biotechnology company, raised $5.5 million in debt, according to a Securities and Exchange Commission filing. Innovate filed the Form D on March 15. The company intends to som... |
| 17.03.2019 | Raleigh-based Innovate Biopharmaceuticals Raises $5.5M by Selling Debt | Innovate Biopharmaceuticals Inc., a Raleigh-based clinical stage biotechnology company, raised $5.5 million in debt, according to a Securities and Exchange Commission filing. Innovate filed the Form D on March 15. The company intends to som... |
Show more